AZENTA INC (AZTA) Stock Price, Quote, News and Overview
NASDAQ:AZTA - Nasdaq - US1143401024 - Common Stock - Currency: USD
AZTA Quote, Performance and Key Statistics
44.75
-0.03 (-0.07%)
The current stock price of AZTA is 44.75 USD. In the past month the price decreased by -18.26%. In the past year, price decreased by -29.38%.
AZTA Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 24.36 | 203.70B | ||
| DHR | DANAHER CORP | 28.07 | 151.18B | ||
| A | AGILENT TECHNOLOGIES INC | 25.59 | 38.62B | ||
| IQV | IQVIA HOLDINGS INC | 17.15 | 33.64B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 31.26 | 26.91B | ||
| WAT | WATERS CORP | 31.58 | 22.26B | ||
| ICLR | ICON PLC | 14.39 | 16.63B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 31.25 | 15.27B | ||
| ILMN | ILLUMINA INC | 38.45 | 14.94B | ||
| RVTY | REVVITY INC | 23.23 | 13.85B | ||
| AVTR | AVANTOR INC | 17.3 | 11.78B | ||
| TEM | TEMPUS AI INC | N/A | 10.72B |
Related stock screener links
About AZTA
Company Profile
Azenta, Inc. is a provider of life sciences sample exploration and management solutions for the life sciences market. The company is headquartered in Burlington, Massachusetts. The Company’s segments include Sample Management Solutions, Multiomics and B Medical Systems. The Sample Management Solutions segment offers end-to-end sample management products and services, including sample and repository services and core products (automated stores, cryogenic systems, automated sample tube, and consumables and instruments). The Multiomics segment provides genomic and other sample analysis services, including gene sequencing and gene synthesis. B Medical Systems segment is focused on the manufacturing and distribution of temperature-controlled storage and transportation solutions in international markets to governments, health institutions, and non-government organizations. The company provides products and services through its brands, including GENEWIZ, FluidX, Ziath, 4titude, Limfinity, Freezer Pro, Barkey, and B Medical Systems.
Company Info
AZENTA INC
200 Summit Drive, 6Th Floor
Burlington MASSACHUSETTS US
Employees: 3300
Company Website: https://www.azenta.com/
Investor Relations: https://investors.azenta.com/
Phone: 19782622400
AZENTA INC / AZTA FAQ
What is the stock price of AZENTA INC today?
The current stock price of AZTA is 44.75 USD. The price decreased by -0.07% in the last trading session.
What is the ticker symbol for AZENTA INC stock?
The exchange symbol of AZENTA INC is AZTA and it is listed on the Nasdaq exchange.
On which exchange is AZTA stock listed?
AZTA stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for AZENTA INC stock?
14 analysts have analysed AZTA and the average price target is 56.61 USD. This implies a price increase of 26.5% is expected in the next year compared to the current price of 44.75. Check the AZENTA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is AZENTA INC worth?
AZENTA INC (AZTA) has a market capitalization of 2.05B USD. This makes AZTA a Mid Cap stock.
How many employees does AZENTA INC have?
AZENTA INC (AZTA) currently has 3300 employees.
What are the support and resistance levels for AZENTA INC (AZTA) stock?
AZENTA INC (AZTA) has a support level at 44.6 and a resistance level at 44.76. Check the full technical report for a detailed analysis of AZTA support and resistance levels.
Is AZENTA INC (AZTA) expected to grow?
The Revenue of AZENTA INC (AZTA) is expected to decline by -9.1% in the next year. Check the estimates tab for more information on the AZTA EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy AZENTA INC (AZTA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of AZTA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of AZTA, evaluating the profitability, health, valuation and growth aspects
- AZENTA INC (AZTA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- AZENTA INC (AZTA) Sales and EPS estimates to see what analysts future expectations are.
- AZENTA INC (AZTA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- AZENTA INC (AZTA) Insider and Institutional Ownership to learn about the owners and their transactions.
- AZENTA INC (AZTA) Stock Chart to make your own analysis
- AZENTA INC (AZTA) Latest news and press-releases to stay up to date.
Does AZENTA INC (AZTA) stock pay dividends?
AZTA does not pay a dividend.
When does AZENTA INC (AZTA) report earnings?
AZENTA INC (AZTA) will report earnings on 2025-05-06, after the market close.
What is the Price/Earnings (PE) ratio of AZENTA INC (AZTA)?
The PE ratio for AZENTA INC (AZTA) is 95.21. This is based on the reported non-GAAP earnings per share of 0.47 and the current share price of 44.75 USD. Check the full fundamental report for a full analysis of the valuation metrics for AZTA.
What is the Short Interest ratio of AZENTA INC (AZTA) stock?
The outstanding short interest for AZENTA INC (AZTA) is 9.16% of its float. Check the ownership tab for more information on the AZTA short interest.
AZTA Technical Analysis
AZTA Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to AZTA. AZTA has a great financial health rating, but its profitability evaluates not so good.
AZTA Financial Highlights
Over the last trailing twelve months AZTA reported a non-GAAP Earnings per Share(EPS) of 0.47. The EPS increased by 113.64% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -7.93% | ||
| ROE | -9.41% | ||
| Debt/Equity | 0 |
AZTA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 74% to AZTA. The Buy consensus is the average rating of analysts ratings from 14 analysts.
For the next year, analysts expect an EPS growth of 24.39% and a revenue growth -9.1% for AZTA